The Petri Dish: Agios licenses Alnylam drug, Ikena acquires startup with Gilead stake

Ikena Oncology is set to acquire a South San Francisco startup after Gilead Sciences waived its exclusive option to buy the company in March. Plus other life sciences news you may have missed.